XML 13 R2.htm IDEA: XBRL DOCUMENT v3.25.1
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Mar. 31, 2025
Dec. 31, 2024
Current assets:    
Cash and cash equivalents $ 60,494 $ 49,464
Marketable securities, available for sale 20,165 43,720
Prepaid expenses and other current assets 1,535 1,542
Total current assets 82,194 94,726
Property and equipment, net 29 34
Other non-current assets 0 866
Total assets 82,223 95,626
Current liabilities:    
Accounts payable 492 559
Accrued expenses 3,744 3,908
Total current liabilities 4,236 4,467
Non-current liabilities:    
Long-term debt, net of discount 31,253 31,134
Total liabilities 35,489 35,601
Commitments and contingencies (see Note 12)
Stockholders' equity:    
Preferred stock, $0.0001 par value; 10,000,000 shares authorized as of March 31, 2025 and December 31, 2024; no shares issued or outstanding as of March 31, 2025 and December 31, 2024 0 0
Common stock, $0.0001 par value; 500,000,000 shares authorized as of March 31, 2025 and December 31, 2024; 59,316,859 and 59,198,230 shares issued as of March 31, 2025 and December 31, 2024, respectively; 59,223,729 and 59,131,149 shares outstanding as of March 31, 2025 and December 31, 2024, respectively 6 6
Additional paid-in capital 301,507 300,520
Accumulated other comprehensive income 11 61
Treasury stock, 93,130 and 67,081 shares as of March 31, 2025 and December 31, 2024, respectively; at cost (124) (107)
Accumulated deficit (254,666) (240,455)
Total stockholders' equity 46,734 60,025
Total liabilities and stockholders' equity $ 82,223 $ 95,626